Norway, Feb. 23 -- Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitoring (CGM) technology, announces that it has signed the EU Declaration of Conformity for the electronics used in its implant system.The Declaration of Conformity confirms that the electronics module complies with the applicable requirements under relevant European directives, including electromagnetic compatibility (EMC) and radio equipment standards, based on completed compliance testing and finalized technical documentation.The Declaration has been issued following receipt and review of the final accredited laboratory test reports for electromagnetic compatibility and radio performance. The technical file supporting th...